Dr. Ankur Bahl

Principal Director – Medical Oncology

Qualifications: MBBS · MD · DM

🏥 Fortis Hospital, FCI Defence Colony, New Delhi

⏱ 15+ years of experience

🌐 Speaks: English, Hindi

Profile Snapshot

• Highly skilled cancer specialist with 15+ years of rich experience in medical oncology
• Alumni of Maulana Azad Medical College, Delhi — DM Medical Oncology from the prestigious AIIMS New Delhi
• Completed a course on Adverse Drug Reactions, Drug Interactions and Pharma Covigilance at the University of Oxford, UK
• Expertise in immunotherapy, targeted therapies, chemotherapy, hormonal therapy, supportive and palliative care
• Lead author of the largest real-world Indian data on targeted therapy (Cetuximab) in Head & Neck cancer
• Lead founder of innovative oncology educational platforms and networks — international and national

Areas of Expertise

• Immunotherapy and Checkpoint Inhibitors
• Targeted Therapy
• Chemotherapy (all lines)
• Hormonal Therapy
• Supportive and Palliative Care
• Head and Neck Cancer (Medical Management)
• Lung Cancer
• Acute Myeloid Leukaemia
• Solid Tumours
• Haematological Malignancies

Work Experience

• Fortis Hospital, FCI Defence Colony — Principal Director, Medical Oncology (Current)
• Fortis Memorial Research Institute, Gurugram — joined from Max Hospital, Saket
• Max Hospital, Saket — Director, Medical Oncology and Haematology Oncology
• Rajiv Gandhi Cancer Institute and Research Centre — Consultant
• Maulana Azad Medical College — Consultant Medical Oncology

Education & Fellowships

• MBBS — Maulana Azad Medical College, Delhi
• MD (Medicine)
• DM Medical Oncology — AIIMS New Delhi
• Course on Adverse Drug Reactions, Drug Interactions and Pharma Covigilance — University of Oxford, UK

Awards & Recognitions

• Lead Author — Largest real world Indian data on Targeted Therapy (Cetuximab) in Head & Neck Cancer
• Lead Author — Acute Myeloid Leukaemia Treatment data
• Lead Author — Human Papilloma Virus trends in Indian Population
• Lead founder of various innovative oncology educational platforms and networks (International and national)
• Evidence based debates in oncology, Live Oncology Tumour boards, Master Classes and workshops

Research & Publications

• Largest real world Indian data on Targeted Therapy (Cetuximab) in Head & Neck Cancer — Lead Author
• Acute Myeloid Leukaemia treatment outcomes — Lead Author
• Human Papilloma Virus trends in Indian Population — Lead Author

Professional Memberships

ESMO · ASCO · Indian Society of Medical and Paediatric Oncology (ISMPO)

Related Pages